Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
2006-11-28
2006-11-28
Housel, James (Department: 1641)
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
C435S004000, C435S007920
Reexamination Certificate
active
07141362
ABSTRACT:
Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.
REFERENCES:
patent: 4325867 (1982-04-01), Eberle et al.
patent: 4601977 (1986-07-01), Ogawa et al.
patent: 4624927 (1986-11-01), Fukushima et al.
patent: 5015588 (1991-05-01), Lee et al.
patent: 5401638 (1995-03-01), Carney et al.
patent: 5688919 (1997-11-01), Hock
patent: 5981180 (1999-11-01), Chandler et al.
patent: 6660486 (2003-12-01), Binder et al.
Katona et al., “Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates”, Journal of Immunological Methods 258 (2001), 127-135.
Katona et al., “Simple, Quick One-step ELISA Assay for the Determination of Complex Plasma Factor XIII (A2B2)”, Thromb. Haemost. 2000, 83: 268-73.
Ariens, et al., “Subunit Antigen and Activity Levels of Blood Coagulation Factor XIII in Healthy Individuals”, Arterioscler. Thromb. Vasc. Biol., Aug. 1999, pp. 2012-2016.
Murdock et al., “Development and Evaluation of ELISAS for Factor XIIIA and XIIIB Subunits in Plasma”, Thrombosis Research, 67; 73-79, 1992.
Achyuthan, K.E. et al. “A microtiter plate assay for factor XIII A-chain-fibrin interactions,”Anal. Biochem. 1994, pp. 43-48, vol. 219.
Ariens et al.; “Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: Relation to sex, age, smoking, and hypertension”; 1999,Arteriosclerosis Thrombosis and Vascular Biology, vol. 19, pp. 2012-2016.
Jenny and Jackson-Tarentino, “Causes of unsatisfactory performance in proficiency testing,”Clinical Chemistry(2000) 46(1):89-99.
Gniewek et al., Monoclonal Antibodies specific for Human Plasma Factor XIII B-subunit and their use in Purification of Human Plasma Factor-XIII by Immunoaffinity Chromatography,Federation Proceedings(1985) 44 (4): 1070.
Katona et al.; “A simple quick one step ELISAS for Factor XIIIA and XIIIB subunits in plasma”; 1992,Thrombosis Research, vol. 67, pp. 268-273.
Kasahara, K. et al., A “subunit of factor XIII present on bovine platelet membrane and mediates collagen-induced platelet activation,”Thrombosis Res. 1988, pp. 253-263, vol. 50.
Mitkevich, O.V. et al. “Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate,”J. Biol. Chem. Jun. 5, 1998, pp. 14387-14391, vol. 273, No. 23.
Murdock et al., “Development and evaluation of elias for factor XIIIA and XIIIB subunits in plasma,”Thrombosis Research(1992) 67: 73-79.
Musbek et al.; “Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function”; 1996,Critical Reviews in Clinical Laboratory Sciences, vol. 33, pp. 357-421.
Nagy et al.; “Biosynthesis of factor XIII B subunit”; 1986,Blood, vol. 68, pp. 1272-1279.
Nonaka et al.; “Molecular cloning of the b subunit of mouse coagulation factor XIII and assignement of the gene to chromosome 1: Close evolutionary relationship to complement factor H”; 1993,Genomics, vol. 15, pp. 535-542.
Schweinie, J.E. et al.; Monoclonal Antibodies Specific for Human Plasma Factor XIII B Subunit and Their Use in the Purification of Human Plasma Factor XIII by Immunoaffinity Chromatography;Blood Coagulation, abstract No. 3857.
Takagi, J. et al. “Subunit B of factor XII is present in bovine platelets,”Thrombosis Res. 1988, pp. 767-774, vol. 50.
Kroll, The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunmoelectrophoresis;Clinica Chemical Acta (1989); vo. 179 pp. 279-284.
Yorifuji et al., B Protein of factor XIII: differentiation between free B and complexed B; Blood (1988); vol. 72 pp. 1645-1650.
Binder Steven R.
Goodrich Jodi L.
Safarian Zara
Bio-Rad Laboratories, Inc.
Heines M. Henry
Housel James
Lam Ann Y.
Townsend and Townsend / and Crew LLP
LandOfFree
FXIII detection for verifying serum sample and sample size... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FXIII detection for verifying serum sample and sample size..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FXIII detection for verifying serum sample and sample size... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3682165